BB
Beacon Biosignals, Inc.
SEC filingOther Technology · Boston, MA
Amount raised$103.3Msold at filing
Total offering$103.3M
Investors in the raise43count reported to the SEC
FiledApr 15, 2026first sale Oct 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Caitlin A. DonovanDirector
Pavel A. RaifeldDirector
Jacob A. Donoghue, M.D., Ph.D.Executive Officer, Director
Jarrett A. RevelsExecutive Officer
Naveen A. RaoDirector
Executive officers, directors and promoters as listed on the Form D.